CONMED Net Profit Margin 2010-2022 | CNMD

CONMED net profit margin from 2010 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
CONMED Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2022-06-30 $1.04B $-0.11B -10.94%
2022-03-31 $1.02B $0.07B 6.57%
2021-12-31 $1.01B $0.06B 6.13%
2021-09-30 $0.99B $0.06B 6.26%
2021-06-30 $0.98B $0.05B 5.52%
2021-03-31 $0.88B $0.01B 1.59%
2020-12-31 $0.86B $0.01B 1.16%
2020-09-30 $0.88B $0.00B 0.11%
2020-06-30 $0.87B $0.00B 0.11%
2020-03-31 $0.95B $0.03B 3.58%
2019-12-31 $0.96B $0.03B 3.04%
2019-09-30 $0.93B $0.03B 3.22%
2019-06-30 $0.90B $0.03B 3.22%
2019-03-31 $0.88B $0.03B 3.66%
2018-12-31 $0.86B $0.04B 4.89%
2018-09-30 $0.84B $0.07B 8.69%
2018-06-30 $0.83B $0.07B 8.94%
2018-03-31 $0.81B $0.07B 8.74%
2017-12-31 $0.80B $0.06B 6.90%
2017-09-30 $0.78B $0.02B 1.93%
2017-06-30 $0.77B $0.02B 1.94%
2017-03-31 $0.77B $0.01B 1.56%
2016-12-31 $0.76B $0.02B 1.97%
2016-09-30 $0.75B $0.02B 2.13%
2016-06-30 $0.73B $0.02B 2.45%
2016-03-31 $0.72B $0.02B 3.05%
2015-12-31 $0.72B $0.03B 4.17%
2015-09-30 $0.72B $0.03B 4.56%
2015-06-30 $0.73B $0.03B 3.57%
2015-03-31 $0.74B $0.03B 3.94%
2014-12-31 $0.74B $0.03B 4.32%
2014-09-30 $0.75B $0.03B 4.14%
2014-06-30 $0.75B $0.04B 4.65%
2014-03-31 $0.76B $0.04B 4.62%
2013-12-31 $0.76B $0.04B 4.72%
2013-09-30 $0.76B $0.04B 4.87%
2013-06-30 $0.76B $0.04B 5.24%
2013-03-31 $0.76B $0.04B 5.26%
2012-12-31 $0.77B $0.04B 5.22%
2012-09-30 $0.75B $0.00B 0.53%
2012-06-30 $0.74B $0.00B 0.40%
2012-03-31 $0.74B $0.00B 0.27%
2011-12-31 $0.73B $0.00B 0.14%
2011-09-30 $0.72B $0.03B 4.56%
2011-06-30 $0.72B $0.03B 4.71%
2011-03-31 $0.72B $0.03B 4.44%
2010-12-31 $0.71B $0.03B 4.21%
2010-09-30 $0.72B $0.03B 3.89%
2010-06-30 $0.72B $0.02B 2.77%
2010-03-31 $0.71B $0.01B 1.98%
2009-12-31 $0.70B $0.01B 1.58%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.967B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $72.810B 21.15
McKesson (MCK) United States $50.991B 14.81
AmerisourceBergen (ABC) United States $30.314B 13.39
West Pharmaceutical Services (WST) United States $24.398B 37.15
Laboratory Of America Holdings (LH) United States $23.439B 10.25
Cardinal Health (CAH) United States $16.828B 12.92
Cooper (COO) United States $16.065B 24.73
Invacare (IVC) United States $0.033B 0.00